WHWK
WHWK
NASDAQ · Biotechnology

Whitehawk Therapeutics Inc

$3.76
+0.02 (+0.53%)
As of Sep 28, 10:20 PM ET ·
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 10 71%
Hold 4 29%
Sell 0 0%
Price Target
Analyst Price Target +360.4% upside
Low Target $14.24
Average Target $17.31
High Target $28.90
Current Price $3.76
Current
$3.76
Target
$17.31
$14.24 $17.31 avg $28.90
Scenario Analysis
Bear Case
$14.24
278.7%
Low target
Base Case
$17.31
+360.4%
Avg target
Bull Case
$28.90
+668.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$5.50
-31.6% from high
52-Week Low
$1.82
+106.6% from low
Target vs 52W High
$17.31
+215.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%